{
    "id": 27249,
    "fullName": "BRCA2 V130_N136delinsD",
    "impact": "indel",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "BRCA2 V130_N136delinsD results in a deletion of seven amino acids of the Brca2 protein from amino acids 130 to 136, combined with the insertion of an aspartate (D) at the same site (UniProt.org). V130_N136delinsD has not been characterized in the scientific literature and therefore, its effect on Brca2 protein function is unknown; however, the corresponding cDNA change has been predicted to act as a reversion mutation in the context of a specific inactivating BRCA2 mutation, potentially leading to restoration of the BRCA2 open reading frame and wild-type protein function, as demonstrated by association with acquired resistance to platinum-based chemotherapy and a PARP inhibitor (PMID: 28765325).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 10297,
                    "pubMedId": 28765325,
                    "title": "Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28765325"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 675,
        "geneSymbol": "BRCA2",
        "terms": [
            "BRCA2",
            "BRCC2",
            "BROVCA2",
            "FACD",
            "FAD",
            "FAD1",
            "FANCD",
            "FANCD1",
            "GLM3",
            "PNCA2",
            "XRCC11"
        ]
    },
    "variant": "V130_N136delinsD",
    "createDate": "11/13/2017",
    "updateDate": "10/07/2019",
    "referenceTranscriptCoordinates": {
        "id": 169004,
        "transcript": "NM_000059",
        "gDna": "chr13:g.32325148_32325165del18",
        "cDna": "c.389_406del18",
        "protein": "p.V130_N136delinsD",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 12300,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, a patient with breast cancer harboring the germline mutation, BRCA2 N136Ifs*16, acquired two BRCA2 reversion mutations, V130_N136delinsD and N136_L139del, as detected in cell-free DNA post treatment with Paraplatin (carboplatin), and subsequently, did not respond to treatment with Talazoparib (BMN-673) (PMID: 28765325).",
            "molecularProfile": {
                "id": 28668,
                "profileName": "BRCA2 V130_N136delinsD BRCA2 N136Ifs*16 BRCA2 N136_L139del"
            },
            "therapy": {
                "id": 682,
                "therapyName": "Talazoparib",
                "synonyms": null
            },
            "indication": {
                "id": 1612,
                "name": "breast cancer",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 10297,
                    "pubMedId": 28765325,
                    "title": "Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28765325"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 28667,
            "profileName": "BRCA2 V130_N136delinsD",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 28668,
            "profileName": "BRCA2 V130_N136delinsD BRCA2 N136Ifs*16 BRCA2 N136_L139del",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 169004,
            "transcript": "NM_000059",
            "gDna": "chr13:g.32325148_32325165del18",
            "cDna": "c.389_406del18",
            "protein": "p.V130_N136delinsD",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}